Onderneming Avalanche Biotechnologies Inc Nasdaq
Aandelen
US05337G1076
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 4 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15-06-20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 12-12-22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/01 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 30-10-19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 21-08-23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 06-01-22 |
Corporate Officer/Principal | - | 25-06-20 | |
Dena House
HRO | Human Resources Officer | - | 01-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 16-04-20 |
Clarence Machado
CHM | Chairman | 60 | 14-03-17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 15-06-20 |
Jim Scopa
BRD | Director/Board Member | 65 | 01-05-19 |
C. Nicholson
BRD | Director/Board Member | 68 | 03/11 |
Mark Lupher
BRD | Director/Board Member | 53 | 01-05-19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 19-02-21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 09-12-20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 17-03-22 |
Soo Hong
BRD | Director/Board Member | 52 | 17-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 756 850 | 20 386 246 ( 98,21 %) | 0 | 98,21 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,03% | 116 mld. | |
+13,17% | 106 mld. | |
-10,23% | 23,89 mld. | |
-1,69% | 21,58 mld. | |
-10,60% | 18,96 mld. | |
-41,25% | 16,96 mld. | |
-14,12% | 16,33 mld. | |
+6,45% | 14,14 mld. | |
+30,02% | 12,02 mld. |